• Steroids, Vaccine Distribution, Depression and Pregnancy Concerns: COVID-19 Updates

    Clinical Research News | A protease inhibitor used to cure a deadly coronavirus-causing disease in cats holds potential for testing in humans, a comparative look at current treatment approaches, proposed Fair Priority Model for vaccine distribution and needed reforms to the FDA’s Emergency Use Authorization process, concerning trends among pregnant women, rising rates of depression, promising news on steroids, and multiple trials on the launch pad—all among the explosion of COVID-19-related news over the past week.

    Sep 4, 2020

  • Clinical Trials For Companion Diagnostic Approval

    Bio-IT World | The regulatory framework around drug and diagnostic co-development, and how to overcome the inevitable hurdles, was the subject of multiple presentations at the 12th Annual Next Generation Dx Summit held virtually last week. Representatives from pharma and FDA weighed in on the clinical trials required to get companion diagnostics to market.

    Sep 2, 2020

  • Don’t Waste A Pandemic: Patient Advocates Call For Continuing Growth Toward Patient Centricity

    Clinical Research News | The COVID-19 pandemic has forced clinical trial sponsors and sites to think outside the box, offering innovative services to help patient recruitment, sample collection, and other phases of clinical research. There’s also another voice that needs to be considered: namely, that of the patient.

    Aug 31, 2020

  • Hydroxychloroquine, Remdesivir, Rehab: COVID-19 Updates

    Clinical Research News | Recommendations for COVID-19 rehabilitation, four months of data from Italy’s use of hydroxychloroquine, more data on which comorbidities are most dangerous, Remdesivir data, and more on imaging. Plus, research grants and a convalescent plasma architecture.

    Aug 28, 2020